Bindu
Bindu Akam, Andhra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20090075636 | METHOD AND SYSTEM FOR TRANSMITTING THE IDENTITY OF A USER IN A MOBILE TELECOMMUNICATIONS NETWORK - The invention consists of a method and a system arranged to transmit an identity of a user from a terminal to a database adapted to permanently store information of said user, in a mobile telecommunications network, comprising: inputting means adapted to allow said user to input said identity at said terminal, whereby said identity is modified on a permanent basis by said user; transmitting means adapted to transmit in the form of a message, said identity from said terminal to said database; storing means adapted upon reception of said message to store said identity at said database. | 03-19-2009 |
Bindu Andreuzza, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20140304854 | METHODS FOR THE IDENTIFICATION OF GENES INVOLVED IN ABIOTIC STRESS TOLERANCE IN PLANTS - Methods are described for the identification of genes useful for conferring tolerance in plants to abiotic stress. Transgenic plants and seeds comprising the stress tolerant genes are also described. Methods to monitor the growth rate of the transgenic plants under stressed or non-stressed conditions are also described. | 10-09-2014 |
Bindu Chandna, Burlington, MA US
Patent application number | Description | Published |
---|---|---|
20100054321 | Systems and Methods that Provide Frequency Domain Supplemental Training of the Time Domain Equalizer for DMT - Using a known or later developed time domain equalizer coefficient training algorithm, a least square solution for the time domain equalizer coefficients is taken at a starting point and iteratively improved on. In particular, the improvement is directed towards maximizing number of bits per frame loaded over the time domain equalizer coefficient choice. This can be accomplished by maximizing capacity directly rather than setting a goal to shorten the channel and hoping that the capacity will be maximized as a result. | 03-04-2010 |
20100290514 | Systems and Methods that Provide Frequency Domain Supplemental Training of the Time Domain Equalizer for DMT - Using a known or later developed time domain equalizer coefficient training algorithm, a least square solution for the time domain equalizer coefficients is taken at a starting point and iteratively improved on. In particular, the improvement is directed towards maximizing number of bits per frame loaded over the time domain equalizer coefficient choice. This can be accomplished by maximizing capacity directly rather than setting a goal to shorten the channel and hoping that the capacity will be maximized as a result. | 11-18-2010 |
20120087399 | Systems and Methods that Provide Frequency Domain Supplemental Training of the Time Domain Equalizer for DMT - Using a known or later developed time domain equalizer coefficient training algorithm, a least square solution for the time domain equalizer coefficients is taken at a starting point and iteratively improved on. In particular, the improvement is directed towards maximizing number of bits per frame loaded over the time domain equalizer coefficient choice. This can be accomplished by maximizing capacity directly rather than setting a goal to shorten the channel and hoping that the capacity will be maximized as a result. | 04-12-2012 |
Bindu Chikkegowda, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20150031056 | DEVELOPMENT OF SPECIFIC IMMUNOASSAY CRITICAL REAGENTS FOR PHARMACOKINETIC ASSESSMENTS OF PEPTIDE POLYMERS IN PRECLINICAL AND CLINICAL MATRICES - The present disclosure provides methods of developing a specific immunoassay for the Pharmacokinetic assessments of peptides, peptide oligomer and polymer including Glatiramer Acetate (GA), also known as Copolymer 1, Copolymer-1, Cop 1 or Cop in the clinical and preclinical matrices. | 01-29-2015 |
Bindu Kodati, Vengal Rao Nagar IN
Patent application number | Description | Published |
---|---|---|
20160046694 | METHODS AND CONSTRUCTS FOR EXPRESSING BIOLOGICALLY ACTIVE PROTEINS IN MAMMALIAN CELLS - Methods and constructs for expressing biologically active proteins in eukaryotic cells are disclosed. A method for producing a non-conventional expression vector for production of biologically active compounds comprising a primary transcriptional unit and one or more secondary transcriptional units, a primary transcriptional unit encoding promoter, synthetic intron, selectable marker gene and polyadenylation signal or transcriptional terminator and a second transcriptional unit encoding promoter and polypeptide of interest surrounded by insulator sequences and placed in the intron of primary transcriptional unit. The synthetic intron disclosed is positioned at the 5′ end of the coding sequence and the synthetic intron capable for accommodating secondary transcriptional unit with base pairs ranging from 500 to 6000 and more. | 02-18-2016 |
Bindu Manojkumar, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100234468 | NOVEL PROCESS - The present invention relates to a process for the preparation of polymorphic forms of the R- and S-enantiomers of modafinil, R-(−)-2-benzhydrylsulfinylacetamide and S-(+)-2-benzhydrylsulfinylacetamide respectively. | 09-16-2010 |
20100234590 | PROCESS FOR THE PURIFICATION NE OF OLANZAPINE - The present invention relates to a novel process for the preparation of pharmaceutically pure olanzapine. The invention is also related to impurities obtained during the preparation of pharmaceutically pure olanzapine and methods for the detection of the impurities. | 09-16-2010 |
20100249162 | PROCESS FOR THE INTRODUCTION OF HYDROXYETHOXY SIDE CHAIN IN BOSENTAN - The present invention relates to an improved process for the preparation of bosentan. In particular it relates to a process for preparing bosentan substantially free from the dimer impurity of formula (II) and the 6-hydroxy impurity of formula (III). The invention also relates to a pharmaceutical composition comprising bosentan and its use in the treatment of endothelin-receptor mediated disorders. | 09-30-2010 |
20100261742 | NOVEL POLYMORPHIC FORMS - Novel polymorphic forms of bosentan and processes for their preparation are disclosed. Further, pharmaceutical compositions comprising said polymorphic forms and the use of said compositions in the treatment of patients suffering from endothelin receptor mediated disorders, for example, cardiovascular disorders such as hypertension, pulmonary hypertension, ischemia, vasospasm and angina pectoris are disclosed. | 10-14-2010 |
20100324139 | PROCESS TO PREGABALIN - The present invention relates to a novel method for the preparation of racemic pregabalin (1) or a single enantiomer thereof, (S)-(+)-3-(aminomethyl)-5-methyl-hexanoic acid (2). | 12-23-2010 |
20110028508 | NOVEL PROCESS FOR THE PREPARATION OF SCOPINE ESTERS - The present invention relates to novel processes for the preparation of scopine esters and their quaternary salts. In particular, the present invention relates to a process for the preparation of tiotropium bromide, pharmaceutical compositions comprising tiotropium bromide and the use of such compositions in the treatment of respiratory disorders. | 02-03-2011 |
20110039871 | PROCESS FOR PREPARING BOSENTAN - The present invention relates to a novel intermediate useful in the preparation of bosentan and to processes for the preparation of said intermediate and bosentan. The invention further relates to compositions comprising bosentan prepared according to the processes of the invention and their use in the treatment of endothelin-receptor mediated disorders. | 02-17-2011 |
20110184071 | PROCESS FOR THE PREPARATION OF AMINES - The present invention relates to an improved process for the preparation of rasagiline (1) and its pharmaceutically acceptable salts. In particular it relates to a process for preparing rasagiline (1) and its salts substantially free from impurities. | 07-28-2011 |
20110251254 | NOVEL SALT OF TEGASEROD - The present invention relates to a novel salt of tegaserod, namely tegaserod suberate, and to processes for the preparation thereof. The invention also relates to crystalline forms of the novel salt and to pharmaceutical compositions comprising the novel salt. Further, the invention relates to uses of said compositions in treating patients suffering from gastrointestinal disorders. | 10-13-2011 |
20110251288 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE AMINES - The present invention relates to an improved process for the preparation of (R)-1-aminoindan (2), rasagiline (1) and pharmaceutically acceptable salts of rasagiline. | 10-13-2011 |
20110263719 | POLYMORPHIC FORM OF RASAGILINE MESYLATE - The present invention relates to a novel crystalline form of rasagiline mesylate and a pure form of rasagiline mesylate and processes for their preparation. Further, the invention relates to pharmaceutical compositions comprising said forms and use of said compositions in the treatment of patients suffering from Parkinson's Disease, dementia, Alzheimer's Disease, depression, hyperactive syndrome, stroke, brain ischemia, neurotrauma, schizophrenia and multiple sclerosis. | 10-27-2011 |
20130303741 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE AMINES - The present invention relates to an improved process for the preparation of (R)-1-aminoindan (2), rasagiline (1) and pharmaceutically acceptable salts of rasagiline. | 11-14-2013 |
Bindu Manojkumar, Panvel IN
Patent application number | Description | Published |
---|---|---|
20130172369 | PROCESSES FOR THE PREPARATION OF DIPYRIDAMOLE - The present invention relates to the active pharmaceutical ingredient dipyridamole. In particular, it relates to efficient processes for the preparation of dipyridamole which are amenable to large scale commercial production and provide the required product with improved yield and purity. The present invention also relates to a novel crystallization method for the purification of dipyridamole. | 07-04-2013 |
Bindu Manojkumar, District Raigad IN
Bindu Manojkumar, Taloja IN
Patent application number | Description | Published |
---|---|---|
20150094320 | PROCESSES FOR THE PREPARATION OF DIPYRIDAMOLE - The present invention relates to the active pharmaceutical ingredient dipyridamole. In particular, it relates to efficient processes for the preparation of dipyridamole which are amenable to large scale commercial production and provide the required product with improved yield and purity. The present invention also relates to a novel crystallization method for the purification of dipyridamole. | 04-02-2015 |
Bindu Mnaojkumar, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090306170 | SYNTHESIS OF TEGASEROD OR A SALT THEREOF - The present invention relates to a novel process for the synthesis of 1-((5-methoxy-1H-indol-3-yl)methyleneamino)-3-pentyl-guanidine, commonly known as tegaserod, which is used as a gastroprokinetic, and salts thereof. The present invention also relates to tegaserod and salts thereof having an HPLC purity of about 95% or more. The present invention further relates to pharmaceutical compositions comprising tegaserod or a salt thereof, second medical uses of tegaserod or a salt thereof, and methods of treating or preventing irritable bowel syndrome using tegaserod or a salt thereof. | 12-10-2009 |
Bindu Rao, Laguna Nigel, CA US
Patent application number | Description | Published |
---|---|---|
20110029607 | Configuring Consumption Of Service For Electronic Devices - One embodiment of a method for configuring consumption of service includes identifying a service to be consumed by a user, identifying a plurality of bearer technologies across which at least one electronic device can access the service, selecting one of the plurality of bearer technologies for use in configuring the at least one electronic device, and configuring the at least one electronic device for the service using one of a plurality of management frameworks according to the selected bearer technology. | 02-03-2011 |
Bindu Raveendra, Jupiter, FL US
Patent application number | Description | Published |
---|---|---|
20150377879 | PEPTOIDS THAT BIND SPECIFIC ANTIGENS - Combinatorial libraries were generated providing a vast number of diverse peptoid ligands. From these libraries, ligands were identified which specifically bind molecules associated with autoimmune diseases, such as antibodies specific to aquaporin-4 (AQP4), binding of which to AQP4 causes the autoimmune disease, Neuoromyelitis Optica. Methods of generating peptoid libraries and for diagnosing Neuromyelitis Optica are also provided. | 12-31-2015 |
Bindu Santhamma, San Antonio, TX US
Patent application number | Description | Published |
---|---|---|
20100261896 | METHODS FOR THE PREPARATION OF DROSPIRENONE - Described herein are methods of making drospirenone. Also described are intermediate compounds that may be used to synthesis drospirenone. | 10-14-2010 |
20130029953 | PROGESTERONE ANTAGONISTS - Described herein are compounds which either act as pure antiprogestins or as antiprogestins with partial agonistic activity and methods of treating cancer using such compounds. | 01-31-2013 |
20130123523 | METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL - Described herein is a process for the synthesis of etonogestrel and desogestrel and intermediates used to form etonogestrel and desogestrel. | 05-16-2013 |
20140364600 | IMIDAZOLYL PROGESTERONE ANTAGONISTS - Described herein are imidazolyl compounds which either act as pure antiprogestins and methods of using such pure antagonists for gynecological indications and breast cancer. | 12-11-2014 |
20150018322 | PRO-DRUG FORMING COMPOUNDS - Various prodrug compounds having the general structure: Active agent-(acid)-(linker)-SO | 01-15-2015 |
Bindu Tejura, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100286105 | METHODS OF TREATING HYPERANDROGENISM AND CONDITIONS ASSOCIATED THEREWITH BY ADMINISTERING A FATTY ACID ESTER OF AN ESTROGEN OR AN ESTROGEN DERIVATIVE - Compositions and methods for treating hyperandrogenism and conditions associated therewith, including polycystic ovary syndrome are disclosed. The invention is directed to methods for treating hyperandrogenism and conditions associated therewith, in a subject comprising administering a fatty acid ester of an estrogen or an estrogen derivative. Furthermore the invention is directed to compositions for treating hyperandrogenism and conditions associated with hyperandrogenism, including polycystic ovary syndrome, comprising a fatty acid ester of an estrogen or an estrogen derivative. | 11-11-2010 |
Bindu Tejura, New York, NY US
Patent application number | Description | Published |
---|---|---|
20080261936 | METHODS OF REDUCING THE BODY WEIGHT OF A SUBJECT BY ADMINISTERING A FATTY ACID ESTER OF AN ESTROGEN OR ESTROGEN DERIVATIVE IN AN OIL AND COMPOSITIONS CONTAINING THE SAME - Compositions and methods for reducing the body weight of a subject are disclosed. The invention is directed to methods for reducing the body weight in a subject comprising administering therapeutically effective amounts of a fatty acid ester of an estrogen or estrogen derivative in an oil. Furthermore the invention is directed to compositions for reducing the body weight in a subject comprising administering therapeutically effective amounts of a fatty acid ester of an estrogen or estrogen derivative in an oil. | 10-23-2008 |